Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Qing-Fang Chen"'
Autor:
You-Yu Gu, Ping Huang, Quan Li, Yu-Ying Liu, George Liu, Yu-Hui Wang, Ming Yi, Li Yan, Xiao-Hong Wei, Lei Yang, Bai-He Hu, Xin-Rong Zhao, Xin Chang, Kai Sun, Chun-Shui Pan, Yuan-Chen Cui, Qing-Fang Chen, Chuan-She Wang, Jing-Yu Fan, Zhi-Zhong Ma, Jing-Yan Han
Publikováno v:
Frontiers in Physiology, Vol 9 (2018)
The purpose of the study was to explore the effect and the underlying mechanism of YangXue QingNao Wan (YXQNW) and Silibinin Capsules (SC), the two Chinese medicines, on cognitive impairment in older people with familial hyperlipidaemia. Fourteen mon
Externí odkaz:
https://doaj.org/article/6eec7c8c4b67469c8b4bc91b2aa6dbd4
Autor:
Jing-Yu Fan, Jing-Yan Han, Qing-Fang Chen, Yu-Ying Liu, Li Yan, Li Quan, Chun-Shui Pan, Xin Chang, Bai-He Hu
Publikováno v:
Stroke. 49(9)
Background and Purpose— tPA (tissue-type plasminogen activator) is the only recommended intravenous thrombolytic agent for ischemic stroke. However, its application is limited because of increased risk of hemorrhagic transformation beyond the time
Publikováno v:
ACTA AGRONOMICA SINICA. 38:43-49
Autor:
Jing-Yan Han, Li Yan, Quan Li, Bing He, Chun-Shui Pan, Ai-Ping Lv, Chuan-She Wang, Yuan-Yuan Chen, Jing-Yu Fan, Yan Bai, Yu-Ying Liu, Qing-Fang Chen, Ke He, Kai Sun
Publikováno v:
Scientific Reports
The present study aimed to explore the holistic mechanism for the antihypertrophic effect of a compound in Chinese medicine, QiShenYiQi Pills (QSYQ) and the contributions of its components to the effect in rats with cardiac hypertrophy (CH). After in
Publikováno v:
2014 International Conference on Power System Technology; 2014, p1652-1656, 5p